Limits...
Intellectual Property: a powerful tool to develop biotech research.

Giugni D, Giugni V - Microb Biotechnol (2010)

Bottom Line: Consequently, investors aim to safeguard as much as possible their investments.Intellectual Property, and in particular patents, has been demonstrated to actually constitute a powerful tool to help them.Moreover, patents represent an extremely important means to disclose biotechnology inventions.

View Article: PubMed Central - PubMed

Affiliation: PROPRIA S.r.l. - Patents Models Trademarks - Via Della Colonna 35, 33170 Pordenone, Italy. dgiugni@propria.it

Show MeSH
Share of biotechnology patent applications in the period 2002–2004 per country/region. Source: ETEPS. Institute for Prospective Technological Studies (IPTS) calculations. RoW, rest of the world.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3815763&req=5

f4: Share of biotechnology patent applications in the period 2002–2004 per country/region. Source: ETEPS. Institute for Prospective Technological Studies (IPTS) calculations. RoW, rest of the world.

Mentions: At last, looking at biotechnology patent applications filed before the EPO over the period 2002–2004, the EU accounted for 35% of all biotechnology applications, whereas 41% could be attributed to the USA (Fig. 4).


Intellectual Property: a powerful tool to develop biotech research.

Giugni D, Giugni V - Microb Biotechnol (2010)

Share of biotechnology patent applications in the period 2002–2004 per country/region. Source: ETEPS. Institute for Prospective Technological Studies (IPTS) calculations. RoW, rest of the world.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3815763&req=5

f4: Share of biotechnology patent applications in the period 2002–2004 per country/region. Source: ETEPS. Institute for Prospective Technological Studies (IPTS) calculations. RoW, rest of the world.
Mentions: At last, looking at biotechnology patent applications filed before the EPO over the period 2002–2004, the EU accounted for 35% of all biotechnology applications, whereas 41% could be attributed to the USA (Fig. 4).

Bottom Line: Consequently, investors aim to safeguard as much as possible their investments.Intellectual Property, and in particular patents, has been demonstrated to actually constitute a powerful tool to help them.Moreover, patents represent an extremely important means to disclose biotechnology inventions.

View Article: PubMed Central - PubMed

Affiliation: PROPRIA S.r.l. - Patents Models Trademarks - Via Della Colonna 35, 33170 Pordenone, Italy. dgiugni@propria.it

Show MeSH